Clinical trials in Bergen Op Zoom

16 clinical trials in Bergen Op Zoom, The Netherlands. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in the NetherlandsKlinischOnderzoek.nl

Bergen Op Zoom at a glance

clinical trials

Paediatric trials0
Research sites0

Quick filters

16 trials in Bergen Op Zoom

Open in trial search

Vitiligo+2

Recruiting

InvestigationalNo placebo

Long-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Povorcitinib
Sponsor:Incyte Corp.

Contact Research Centre

Human papilloma virus immunisation+1

Recruiting

Registered drug

Study on HPV Vaccine for Women with Vulvar HSIL: Evaluating the Effectiveness of Nonavalent HPV Vaccine in Preventing Recurrence of Vulvar High-Grade Lesions

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Human Papillomavirus Type 11 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Contact Research Centre

Study on the Effects of Baricitinib and Drug Combination for Adults with Severe Community-Acquired Pneumonia, Severe Influenza, or Severe and Moderate COVID-19

Recruiting

Registered drugNo placebo

Study on the Effects of Baricitinib and Drug Combination for Adults with Severe Community-Acquired Pneumonia, Severe Influenza, or Severe and Moderate COVID-19

Registered drugNo placebo

The Netherlands

Participants:0–17 years · 18–64 years · 65+ years
Substances:Amoxicillin Sodium
Sponsor:Universitair Medisch Centrum Utrecht

Contact Research Centre

Arteriosclerosis

Not yet recruiting

Investigational

A study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Sponsor:Eli Lilly & Co.

Contact Research Centre

Dermatitis atopic

Not recruiting

Investigational

Study of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis

Investigational

The Netherlands

Participants:0–17 years · 18–64 years · 65+ years
Substances:Rocatinlimab
Sponsor:Amgen Inc.

Contact Research Centre

Hidradenitis

Not recruiting

Registered drug

Study on Long-term Effects of Secukinumab in Patients with Moderate to Severe Hidradenitis Suppurativa

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Secukinumab
Sponsor:Novartis Pharma AG

Contact Research Centre

Chronic spontaneous urticaria

Not recruiting

Registered drug

Study on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Barzolvolimab
Sponsor:Celldex Therapeutics Inc.

Contact Research Centre

Vitiligo

Not recruiting

Investigational

Study on the Effects of Upadacitinib in Adults and Adolescents with Non-Segmental Vitiligo Eligible for Systemic Treatment

Investigational

The Netherlands

Participants:0–17 years · 18–64 years · 65+ years
Substances:Upadacitinib
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Vitiligo

Not recruiting

Investigational

Study on the Effectiveness of Povorcitinib for Adults with Nonsegmental Vitiligo

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Substances:Povorcitinib
Sponsor:Incyte Corp.

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drug

Study of Rocatinlimab with Topical Treatments for Adults with Moderate to Severe Atopic Dermatitis

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Rocatinlimab
Sponsor:Amgen Inc.

Contact Research Centre

Dermatitis atopic

Not recruiting

Investigational

Study on the Effectiveness of Ruxolitinib Cream for Adults with Moderate Atopic Dermatitis

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Substances:Ruxolitinib
Sponsor:Incyte Corp.

Contact Research Centre

B-cell lymphoma+1

Not recruiting

Registered drugNo placebo

Study on Epcoritamab, Rituximab, and Lenalidomide for Adults with Untreated Follicular Lymphoma

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Other cities in the Netherlands

The busiest research cities in the country

All 103 cities in the Netherlands

Clinical research in Bergen Op Zoom

What the registry says about research in the country

01 Dermatological Conditions

Extensive research focusing on atopic dermatitis treatments, including studies of novel therapeutic approaches using upadacitinib and lebrikizumab for moderate to severe cases.

Atopic Dermatitis Management
Topical Treatment Studies
Long-term Efficacy Research

Investigating combination therapies with topical corticosteroids for enhanced treatment outcomes.

02 Skin Disorders

Innovative trials exploring treatments for vitiligo and chronic spontaneous urticaria, with breakthrough medications like povorcitinib and barzolvolimab under investigation.

Vitiligo Treatment Development
Urticaria Management
Therapeutic Innovation

Focus on developing systemic therapies for previously difficult-to-treat conditions.

03 Complex Medical Conditions

Studies addressing challenging conditions including chronic venous ulcers and hidradenitis suppurativa, utilizing advanced therapeutic approaches like stem cell treatments.

Wound Healing Research
Inflammatory Disease Studies
Novel Treatment Approaches

Evaluating long-term effectiveness and safety profiles of innovative therapies.

Back to the Netherlands All countries